26 Jul 2023

UniSuper awards mandate to NorthStar Impact

UniSuper, the award-winning over $120bn super fund, has appointed NorthStar Impact as a specialist external listed equities manager.
Continue Reading »
13 Oct 2022

Botanix delivers clinically meaningful results in its BTX 1702 Phase 1b/2 clinical study

Botanix Pharmaceuticals has announced its BTX 1702 Phase 1b/2 clinical study on papulopustular rosacea has produced clinically meaningful data. 
Continue Reading »
12 Oct 2022

Volpara Receives B Corp Certification

Volpara Health Technologies (“Volpara”), which provides clinically validated software for the early detection of breast cancer, has been certified
Continue Reading »
« Previous Page